| Application no. and date | 15778162.6 (espacenet) (Federated) (European Patent Register), 20150929 | | Patent/reg. no. and date | DK/EP 3201203, 20210519 | | Publication date | 20170809 | | Priority no. and date | US 201462056982 P, 20140929 | | EP pub. no. and date |
EP 3201203 20170809 | | Effective date | | | Applicant/owner | Takeda Pharmaceutical Company Limited, 1-1 Doshomachi 4-chome Chuo-ku
Osaka-shi, Osaka 541-0045, JP | | Applicant ref. no. | 165051/BT/SD | | Inventor | ZHAO, Yuxin, c/o Takeda California Inc.
10410 Science Center Drive
San Diego, California 92121, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/5386 (2006.01) , A61P 1/00 (2006.01) , A61P 1/08 (2006.01) , A61P 25/06 (2006.01) , A61P 25/16 (2006.01) , A61P 25/18 (2006.01) , A61P 25/22 (2006.01) , A61P 25/24 (2006.01) , A61P 25/30 (2006.01) , C07D 498/08 (2006.01) | | Title | KRYSTALLINSK FORM AF 1-(1-METHYL-1H-PYRAZOL-4-YL)-N-((1R,5S,7S)-9-METHYL-3-OXA-9-AZABICYCLO[3.3.1]NONAN-7-YL)-1H-INDOL-3-CARBOXAMID | | Int. application no. | US2015052806 | | Int. publication no. | WO2016053947 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
